Also see: Red Hat, Celgene: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

STOCK COMMENTS / EPS CHANGES

Bruker

(BRKR) - Get Report

estimates, target boosted at UBS. Shares of BRKR now seen reaching $23, according to UBS. Estimates also upped, as the company is realizing higher organic growth. Buy rating.

Caterpillar

(CAT) - Get Report

estimates, target upped at Morgan Stanley. CAT estimates were boosted through 2012. Company is expanding its margins. Overweight rating and new $120 price target.

Comcast

(CMCSA) - Get Report

estimates, target raised at Morgan Stanley. Shares of CMCSA now seen reaching $27, according to Morgan Stanley. Estimates also increased, as the company is signing more subscribers and seeing higher video revenue. Equal-weight rating.

Dollar Tree

(DLTR) - Get Report

numbers increased at Goldman. DLTR estimates were raised through 2012, Goldman Sachs said. Company is generating solid comp sales growth. Neutral rating and new $61 price target.

Amdocs

(DOX) - Get Report

estimates, target upped at Goldman. DOX estimates were boosted through 2013, Goldman Sachs said. Company is leveraged to higher carrier spending. Neutral rating and new $32 price target.

DirecTV

(DTV)

estimates, target raised at Goldman. Shares of DTV now seen reaching $55, according to Goldman Sachs. Estimates also increased, given higher subscriber and sales growth. Buy rating.

Echo Global Logistics

(ECHO) - Get Report

estimates changed at Credit Suisse. ECHO 2011 EPS estimate lowered to $0.59, 2012 raised to $0.82. 4Q10 results show business model is working, Credit Suisse said. Maintain Outperform rating and $16 price target.

Fleetcor

(FLT) - Get Report

estimates, target boosted at Goldman. Shares of FLT now seen reaching $33, according to Goldman Sachs. Estimates also upped, to match the company's new guidance. Neutral rating.

National CineMedia

(NCMI) - Get Report

estimates cut at Credit Suisse. NCMI 2011 and 2012 EPS estimates lowered to $0.79 and $0.90, respectively. Positive 4Q10 results despite short-term hit from military contract loss, Credit Suisse said. Maintain Outperform rating and $21 price target.

Nuvasive

(NUVA) - Get Report

estimates, target boosted at Goldman. Shares of NUVA now seen reaching $28, according to Goldman Sachs. Estimates also upped, as the company is seeing better end-market demand. Neutral rating.

Priceline.com

(PCLN)

estimates, target raised at Goldman. Shares of PCLN now seen reaching $525, according to Goldman Sachs. Estimates also increased, given higher expected sales and a lower tax rate. Buy rating.

PS Business Parks

(PSB) - Get Report

price target boosted at Credit Suisse. PSB price target raised to $69 from $67. The PSA loan was an unequivocal positive, Credit Suisse said. Maintain Outperform rating.

Fresh Market

(TFM)

numbers upped at Goldman. TFM estimates were boosted through 2012, Goldman Sachs said. Company is realizing operating leverage. Neutral rating and new $36 price target.

TJX Companies

(TJX) - Get Report

numbers boosted at Goldman. Shares of TJX now seen reaching $54, according to Goldman Sachs. Estimates also upped, as the company is realizing higher margins. Neutral rating.

Vertex Pharmaceuticals

(VRTX) - Get Report

numbers increased at Goldman. VRTX estimates were raised through 2015, Goldman Sachs said. New cystic fibrosis study improves the likelihood of FDA approval. Buy rating and new $49 price target.

Wellpoint

(WLP)

estimates, target raised at Goldman. Shares of WLP now seen reaching $75, according to Goldman Sachs. Estimates also increased, as the company is seeing higher sales. Neutral rating.

This article was written by a staff member of TheStreet.